GeneDx Holdings WGS Net proceeds from sales of subsidiary shares
Net proceeds from sales of subsidiary shares at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceInitialPublicOffering.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's net proceeds from sales of subsidiary shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's net proceeds from sales of subsidiary shares?
- GeneDx Holdings (WGS) reported net proceeds from sales of subsidiary shares of $97M in Q1 2026.
- How has GeneDx Holdings's net proceeds from sales of subsidiary shares changed year-over-year?
- GeneDx Holdings's net proceeds from sales of subsidiary shares increased by 598.1% year-over-year, from $13.89M to $97M.
- What does net proceeds from sales of subsidiary shares mean?
- This captures the net cash inflows received from the issuance of equity securities during an initial public offering. It serves as a primary indicator of the company's ability to raise external capital to fund growth and operational scaling.